| 10:00 – 12:00 PAH: Pulmonary Arterial Hypertension (PAH)-CHD | |
|---|---|
| 10:00 – 10:20 | Pathophysiology of pulmonary hypertension in congenital heart disease |
| 10:20 – 10:40 | Operability in PAH-CHD |
| 10:40 – 11:00 | Management of Eisenmenger syndrome |
| 11:00 – 11:20 | Evaluation and management of pulmonary hypertension in children with end stage left heart failure |
| 11:20 – 11:40 | PAH in the child with Down Syndrome |
| 11:40 – 12:00 | Persistent postoperative PAH |
| 13:30 – 15:30 PAH: Treatment of Pulmonary Arterial Hypertension (PAH) | |
|---|---|
| 13:30 – 13:50 | General measures |
| 13:50 – 14:10 | cGMP Treatment |
| 14:10 – 14:30 | Prostacyclin Treatment |
| 14:30 – 14:50 | Endothelin Receptor Antagonist Treatment |
| 14:50 – 15:10 | Interventional Approaches in Pulmonary Hypertension (BAS/Cath Potts) |
| 15:10 – 15:30 | Surgical Approaches in PAH (Potts/Transplant) |